Pharvaris N.V.
PHVS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,000 | $974 | $353 | $385 |
| - Cash | $281 | $391 | $162 | $209 |
| + Debt | $1 | $0 | $0 | $0 |
| Enterprise Value | $720 | $583 | $191 | $176 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$146 | -$97 | -$87 | -$54 |
| % Margin | – | – | – | – |
| Net Income | -$134 | -$101 | -$76 | -$43 |
| % Margin | – | – | – | – |
| EPS Diluted | -2.48 | -2.63 | -2.27 | -1.41 |
| % Growth | 5.7% | -15.9% | -61% | – |
| Operating Cash Flow | -$120 | -$93 | -$67 | -$45 |
| Capital Expenditures | -$1 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$121 | -$93 | -$67 | -$45 |